TIGAR and ovarian serous adenocarcinoma: Importantly, TCGA data analysis indicates that higher expression of TIGAR is observed in many different cancer types, and patients with higher TIGAR expression show poor overall survival outcome in high-grade serous ovarian cancer (Fig. 7).